BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 19892433)

  • 1. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
    Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
    J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
    Alkawas AA; Shahien EA; Hussein AM
    J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab in a patient with neovascular glaucoma.
    Kahook MY; Schuman JS; Noecker RJ
    Ophthalmic Surg Lasers Imaging; 2006; 37(2):144-6. PubMed ID: 16583637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma.
    Iliev ME; Domig D; Wolf-Schnurrbursch U; Wolf S; Sarra GM
    Am J Ophthalmol; 2006 Dec; 142(6):1054-6. PubMed ID: 17157590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
    Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.
    Batioğlu F; Astam N; Ozmert E
    Int Ophthalmol; 2008 Feb; 28(1):59-61. PubMed ID: 17609852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bevacizumab as adjuvant for neovascular glaucoma.
    Beutel J; Peters S; Lüke M; Aisenbrey S; Szurman P; Spitzer MS; Yoeruek E; ; Grisanti S
    Acta Ophthalmol; 2010 Feb; 88(1):103-9. PubMed ID: 18811641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.
    Kitnarong N; Chindasub P; Metheetrairut A
    Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab in conjunction with panretinal photocoagulation for neovascular glaucoma.
    Wasik A; Song HF; Grimes A; Engelke C; Thomas A
    Optometry; 2009 May; 80(5):243-8. PubMed ID: 19410229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.
    Yazdani S; Hendi K; Pakravan M
    J Glaucoma; 2007 Aug; 16(5):437-9. PubMed ID: 17700285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of neovascular glaucoma with transscleral cyclophotocoagulation with diode laser alone versus combination transscleral cyclophotocoagulation with diode laser and intravitreal bevacizumab.
    Fong AW; Lee GA; O'Rourke P; Thomas R
    Clin Exp Ophthalmol; 2011; 39(4):318-23. PubMed ID: 20973900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion.
    Vatavuk Z; Bencic G; Mandic Z
    Eur J Ophthalmol; 2007; 17(2):269-71. PubMed ID: 17415704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
    Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
    Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravitreal bevacizumab in the treatment of neovascular glaucoma].
    Ouhadj O; Chergui I; Mendil L; Nouri MT
    J Fr Ophtalmol; 2009 Feb; 32(2):112-6. PubMed ID: 20579473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination intravitreal bevacizumab/panretinal photocoagulation versus panretinal photocoagulation alone in the treatment of neovascular glaucoma.
    Ehlers JP; Spirn MJ; Lam A; Sivalingam A; Samuel MA; Tasman W
    Retina; 2008 May; 28(5):696-702. PubMed ID: 18463512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
    Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
    J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracameral bevacizumab for iris rubeosis.
    Grisanti S; Biester S; Peters S; Tatar O; Ziemssen F; Bartz-Schmidt KU;
    Am J Ophthalmol; 2006 Jul; 142(1):158-60. PubMed ID: 16815268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab combined with panretinal photocoagulation in the treatment of open angle neovascular glaucoma.
    Ciftci S; Sakalar YB; Unlu K; Keklikci U; Caca I; Dogan E
    Eur J Ophthalmol; 2009; 19(6):1028-33. PubMed ID: 19882572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous intravitreal and intracameral injection of bevacizumab (Avastin) in neovascular glaucoma.
    Yuzbasioglu E; Artunay O; Rasier R; Sengul A; Bahcecioglu H
    J Ocul Pharmacol Ther; 2009 Jun; 25(3):259-64. PubMed ID: 19348598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of trabeculectomy with anti-VGEF therapy in the treatment of neovascular glaucoma secondary to retinal vein occlusion (report of 21 cases followed at Bukavu Eye Clinic from January 1 to December 31th, 2015)].
    Kabesha TB; Kabesha D; Maloba V; Mwamba C; Chenge B; Mukalay A
    J Fr Ophtalmol; 2017 Jan; 40(1):17-21. PubMed ID: 27884546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.